This Article Abstract Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hirai, M. Articles by Toyota, T. Search for Related Content PubMed PubMed Citation Articles by Hirai, M. Articles by Toyota, T.

Variations in Vitamin D-Binding Protein (Group-Specific Component Protein) Are Associated with Fasting Plasma Insulin Levels in Japanese with Normal Glucose Tolerance¹

The Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, 980-8574 Japan

Address correspondence and requests for reprints to: Susumu Suzuki, M.D., The Third Department of Internal Medicine, Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574 Japan.

	Abstract

Top Abstract Introduction Subjects and Methods Results Discussion References

 
The locus of the vitamin D-binding protein (DBP; also known as group-specific component protein or Gc) gene, chromosome 4q12, has been reported to be associated with glucose metabolism in several ethnic groups, including Pima Indians. We have recently reported the association of the DBP genotype with type 2 diabetes mellitus in Japan. The aim of this study was to investigate whether genetic variations of DBP have any influence on glucose metabolism without secondary effects of hyperglycemia or diabetes mellitus using 82 Japanese with normal glucose tolerance. The variations of the DBP gene (Gc 1F, 1S, and 2) were determined by PCR-restriction fragment length polymorphism. Fasting plasma insulin concentration and homeostasis model assessment, an index of insulin resistance, were significantly different based on the DBP genotype (P < 0.01 and P < 0.05, respectively). The people with Gc 1S-2 (5.73 ± 2.57 µU/mL) and 1S-1S (5.30 ± 3.46 µU/mL) had significantly higher fasting plasma concentrations than those with 1F-1F (2.84 ± 1.67 µU/mL) (P < 0.01 and P < 0.03, respectively). There was no significant difference in plasma glucose concentration, body mass index, total cholesterol, triglyceride, and blood pressure. In conclusion, genetic variations of DBP are associated with insulin resistance in Japanese with normal glucose tolerance, which might contribute to the development of type 2 diabetes.

	Introduction

Top Abstract Introduction Subjects and Methods Results Discussion References

 
VITAMIN D-BINDING PROTEIN (DBP), also known as group-specific component protein (Gc), is a multifunctional serum glycoprotein (1). DBP is the major serum transport protein for the vitamin D sterols (2). There are three major electrophoretic variants of the DBP glycoprotein, which differ by amino acid substitutions, as well as attached polysaccharide. These variants are called Gc 1F, Gc 1S, and Gc 2, since DBP has been historically known as group- specific component protein (Gc), and they are characterized by polymorphisms in exon 11 (Asp/Glu at codon 416, Thr/Lys at codon 420 (1).

The DBP gene maps to chromosome 4q12. It has recently been found that the locus of the DBP gene was linked to plasma glucose and insulin concentrations in nondiabetic Pima Indians (3). DBP is associated with type 2 diabetes in seven Polynesian Island populations (4). In a Hispanic-American/Anglos population of the San Luis Valley in Colorado, a variation in DBP is associated with elevated plasma glucose (5), and in Dogrib Indians, DBP is associated with both fasting insulin and glucose concentrations (6, 7). Furthermore, recently, variations of DBP have been found to be associated with oral glucose tolerance in nondiabetic Pima Indians (8). We have reported that the DBP genotype is associated with type 2 diabetes mellitus in Japan (9). Thus, the purpose of this study was to investigate whether genetic variations of DBP have any influence on glucose metabolism without secondary effects of hyperglycemia or diabetes mellitus using Japanese subjects with normal glucose tolerance.

	Subjects and Methods

Top Abstract Introduction Subjects and Methods Results Discussion References

 
Eighty-two Japanese with normal glucose tolerance (47 males and 35 females) were employed in this study. They all showed normal glucose tolerance by 75 g oral glucose tolerance test. The criteria used in this study was the former diagnostic criteria of the Japanese Diabetes Society (1982), in which normal glucose tolerance was defined by a plasma glucose concentration of lower than 110 mg/dL before glucose load and 120 mg/dL at 2 h after 75 g glucose oral administration. Their clinical characteristics are shown in Table 1. The study protocol was approved by the Tohoku University Institutional Review Board. Informed consent was obtained from each subject.

DBP polymorphisms in exon 11 [Asp(GAT)/Glu(GAG) at codon 416, Thr(ACG)/Lys(AAG) at codon 420] were determined by PCR- restriction fragment length polymorphism. DNA was extracted from blood. A region of exon 11 was specifically amplified by PCR using the primers: forward, 5'-ACATGTAGTAAGACCTTA-3'; and reverse, 5'-GATTGGAGTGCATACGTT-3'. The PCR product was digested by HaeIII and StyI. Digested DNA fragments were electrophoresed by agarose gel and visualized by ultraviolet light. In the amplified region, the Gc 1F allele has neither HaeIII nor StyI site. The Gc 1S allele has the HaeIII but not the StyI site. The Gc 2 allele has the StyI but not the HaeIII site. DBP genotypes were determined by these polymorphic patterns.

Biochemical analysis

The blood glucose concentration was determined by glucose oxidase method. Plasma insulin concentration was measured by RIA.

Homeostasis model assessment (HOMA)

Insulin resistance was assessed by calculating HOMA(R) using the fasting plasma glucose and insulin concentrations (10). HOMA(R) is calculated as fasting plasma glucose concentration (mg/dL) x fasting plasma insulin concentration (µU/mL)/405

Statistical analysis

Statistical analysis was performed by one-way ANOVA and Fisher’s PLSD test.

	Results

Top Abstract Introduction Subjects and Methods Results Discussion References

 
The fasting plasma insulin concentrations were significantly different according to the DBP genotype (P < 0.01) (Table 2). Individuals with Gc 1S-2 and those homozygous for Gc 1S had the highest and the second highest fasting insulin concentrations, respectively. Individuals homozygous for the Gc 1F allele had the lowest insulin concentrations. HOMA(R) also differed according to the DBP genotype (P < 0.05) (Table 2). Plasma insulin concentrations at 2 h after glucose load, glucose concentrations (fasting and 2 h after 75 g glucose load), body mass index (BMI), total cholesterol, triglyceride, blood pressure, and leptin concentrations did not show any significant difference (data not shown). Fasting insulin levels and HOMA(R) were significantly different based on the presence of the three different alleles (P < 0.01 and 0.05, respectively) (Table 3). Individuals with the Gc 1S allele had the highest fasting insulin concentrations, those with the Gc 2 allele had the second highest, and those with the Gc 1F allele had the lowest insulin concentrations. The same trend was observed in HOMA(R).

	Discussion

Top Abstract Introduction Subjects and Methods Results Discussion References

The mechanisms of the association are not clear at present. However, there are several possibilities. DBP is a carrier protein for vitamin D hormone and the affinity of DBP for 1,25 (OH)₂ vitamin D₃, and 25-OH-vitamin D₃ differs depending on the genotype of DBP (11). 1,25 (OH)₂ vitamin D₃ is essential for normal insulin secretion (12). It enhances insulin sensitivity in the people with renal failure (13), and the level of 25-OH-vitamin D₃ is associated with insulin resistance (14). Thus, it is possible that DBP affects glucose metabolism by modulating the action of metabolites of vitamin D. Another possibility is a different role of DBP. DBP is known as a macrophage-activating factor (15), and DBP plays a role in the immune system. Several cytokines, such as tumor necrosis factor , play important roles in insulin sensitivity. Thus, different DBP variants affect the immune response differently, resulting in a change in insulin sensitivity. Furthermore, another possibility would be that the association between DBP and the insulin concentration reflects a linkage of insulin sensitivity with an unknown gene located close to the DBP locus.

	Acknowledgments

 
We thank Youji Kumagai for excellent technical assistance.

	Footnotes

 
¹ Supported in part by a Grant for Diabetes Research from the Ministry of Health and Welfare and a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan.

Received July 20, 1999.

Revised January 4, 2000.

Accepted January 6, 2000.

	References

Top Abstract Introduction Subjects and Methods Results Discussion References

 

1. Braun A, Kofler A, Moraweitz S, Cleve H. 1993 Sequence and organization of the human vitamin D-binding protein gene. Biochim Biophys Acta. 1216:385–394.[Medline]
2. Daiger SP, Schanfield MS, Cavalli-Sforza LL. 1975 Human group-specific component (Gc) proteins bind vitamin D, and 25-hydroxy-vitamin D. Proc Natl Acad Sci USA. 72:2076–2080.[Abstract/Free Full Text]
3. Pratley RE, Thompson DB, Prochazka M, et al. 1998 An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest 101:1757–1764.
4. Kirk RL, Serjeantson SW, Zimmet P. 1982 Genes and diabetes in the Pacific. In: Mimura G, Baba S, Goto Y, Kobberling J, eds. Clinicogenetic genesis of diabetes mellitus. Amsterdam: Excepta Medica; 34–41.
5. Iyengar S, Hamman RF, Marshall JA, Majumder PP, Ferrell RE. 1989 On the role of vitamin D binding globulin in glucose homeostasis: results from the San Luis Valley Study Group. Genet Epidemiol. 6:691–698.[CrossRef][Medline]
6. Szathmary EJE. 1987 The effect of Gc genotype on fasting insulin level in Dogrib Indians. Hum Genet. 75:368–372.[CrossRef][Medline]
7. Szathmary EJE. 1985 The search for genetic factors controlling plasma glucose levels in Dogrib Indians. In: Chakraborty R, Szathmary EJE, eds. Diseases of complex etiology in small populations: ethnic differences and research approaches. New York: Liss; 199–225.
8. Baier LJ, Dobberfuhl AM, Pratley RE, Hanson RL, Bogardus C. 1998 Variations in the vitamin D-binding protein (Gc locus) are associated with oral glucose tolerance in nondiabetic Pima Indians. J Clin Endocrinol Metab. 83:2993–2996.[Abstract/Free Full Text]
9. Hirai M, Suzuki S, Hinokio Y, et al. 1998 Group specific component protein genotype is associated with NIDDM in Japan. Diabetologia. 41:742–743.[CrossRef][Medline]
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985 Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:412–419.[CrossRef][Medline]
11. Arnaud J, Constans J. 1993 Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet. 92:183–188.[Medline]
12. Kadowaki S, Norman AW. 1985 Demonstration that the vitamin D metabolite 1,25(OH) ₂-vitamin D₃ and not 24R,25(OH) ₂-vitamin D₃ is essential for normal insulin secretion in the perfused rat pancreas. Diabetes. 34:315–320.[Abstract]
13. Mak RHK. 1992 Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients. Pediatr Nephrol. 6:345–348.[CrossRef][Medline]
14. Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH, Ljunghall SL. 1995 Vitamin D is related to blood pressure, and other cardiovascular risk factors in middle-aged men. Am J Hypertens. 8:894–901.[CrossRef][Medline]
15. Yamamoto N, Homma S. 1991 Vitamin D binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc Natl Acad Sci USA. 88:8539–8543.[Abstract/Free Full Text]

This article has been cited by other articles:

				P. V. Rao, X. Lu, M. Standley, P. Pattee, G. Neelima, G. Girisesh, K.V. Dakshinamurthy, C. T. Roberts Jr., and S. R. Nagalla Proteomic Identification of Urinary Biomarkers of Diabetic Nephropathy Diabetes Care, March 1, 2007; 30(3): 629 - 637. [Abstract] [Full Text] [PDF]

				M. A. Pani, K. Regulla, M. Segni, S. Hofmann, M. Hufner, A. M. Pasquino, K.-H. Usadel, and K. Badenhoop A Polymorphism within the Vitamin D-Binding Protein Gene Is Associated with Graves' Disease but Not with Hashimoto's Thyroiditis J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2564 - 2567. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hirai, M. Articles by Toyota, T. Search for Related Content PubMed PubMed Citation Articles by Hirai, M. Articles by Toyota, T.